European Congress of Clinical Microbiology & Infectious Diseases

European Congress of Clinical Microbiology & Infectious Diseases
Name	European Congress of Clinical Microbiology & Infectious Diseases
Abbreviation	ECCMID
Established	1983
Frequency	Annual
Location	Varies (Europe)
Discipline	Clinical microbiology; Infectious diseases
Organizer	European Society of Clinical Microbiology and Infectious Diseases

European Congress of Clinical Microbiology & Infectious Diseases is an annual scientific meeting that convenes clinicians, microbiologists, epidemiologists, and public health specialists to present research, policy, and clinical practice advances. The congress assembles delegates from academic institutions, hospitals, public health agencies, pharmaceutical companies, and non-governmental organizations to exchange data on pathogen biology, antimicrobial therapy, diagnostics, and infection prevention. The meeting routinely features plenaries, symposia, poster sessions, industry exhibitions, and educational courses.

Overview

The congress functions as a focal point for interaction among specialists affiliated with European Society of Clinical Microbiology and Infectious Diseases, World Health Organization, European Centre for Disease Prevention and Control, Centers for Disease Control and Prevention, and national institutes such as Robert Koch Institute, Institut Pasteur, National Institute for Health and Care Research, Karolinska Institutet, St George's, University of London, Charité – Universitätsmedizin Berlin, University of Oxford, University of Cambridge, Johns Hopkins University, Harvard Medical School, Imperial College London, University of Paris, KU Leuven, University of Barcelona, University of Milan, University of Amsterdam, University of Zurich, University of Copenhagen, Trinity College Dublin, University of Helsinki, University of Oslo, University of Munich, University of Edinburgh, University of Glasgow, McGill University, University of Toronto, Monash University, University of Tokyo, Peking University, National University of Singapore, Seoul National University Hospital, Mayo Clinic, Cleveland Clinic, King's College London, London School of Hygiene & Tropical Medicine, European Medicines Agency, Food and Drug Administration, Bill & Melinda Gates Foundation, Gavi, the Vaccine Alliance, Médecins Sans Frontières, Wellcome Trust, European Commission for Health Policy. Representatives present work on pathogens including Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, Mycobacterium tuberculosis, Clostridioides difficile, Neisseria gonorrhoeae, Streptococcus pneumoniae, Candida albicans, Aspergillus fumigatus, Cryptococcus neoformans, SARS-CoV-2, Influenza A virus, HIV/AIDS, Ebola virus, Zika virus, Dengue virus, West Nile virus, Chikungunya virus, and Enterococcus faecalis.

History and Development

The congress traces origins to meetings organized by the European Society of Clinical Microbiology and Infectious Diseases in the early 1980s, influenced by parallel gatherings such as the International Congress of Microbiology, Interscience Conference on Antimicrobial Agents and Chemotherapy, Infectious Diseases Society of America annual meeting, and regional events like the British Infection Association conferences. Early sessions reflected priorities of institutions including Institut Pasteur, Robert Koch Institute, National Institutes of Health, Wellcome Trust, and Royal Society of Medicine. Over time the program expanded to address emergent threats highlighted by Severe Acute Respiratory Syndrome, Middle East respiratory syndrome, H1N1 influenza pandemic, Ebola virus epidemic in West Africa, and the COVID-19 pandemic, prompting collaborations with bodies such as World Health Assembly and G7 Summit health delegations. The congress migrated among host cities linked to venues associated with organizations like Fira de Barcelona, Messe Berlin, Palais des Congrès de Paris, Rai Amsterdam, and IFEMA Madrid.

Organization and Governance

Governance is overseen by the board and committees of the European Society of Clinical Microbiology and Infectious Diseases, with program committees drawing members from universities and agencies including Karolinska Institutet, University of Oxford, Charité – Universitätsmedizin Berlin, Imperial College London, University of Cambridge, University of Milan, KU Leuven, University of Barcelona, National Institute for Health and Care Research, Robert Koch Institute, Institut Pasteur, European Centre for Disease Prevention and Control, and World Health Organization technical advisors. Sponsorship and exhibition involve partnerships with pharmaceutical companies such as Pfizer, Roche, GlaxoSmithKline, AstraZeneca, Novartis, Merck & Co., Sanofi, Bayer, AbbVie, Gilead Sciences, Bristol Myers Squibb, Johnson & Johnson, and diagnostic firms including Roche Diagnostics, Siemens Healthineers, BioMérieux, Thermo Fisher Scientific, and Abbott Laboratories. Ethical oversight engages organizations like European Medicines Agency and academic review panels from institutions such as Harvard Medical School and Johns Hopkins University.

Scientific Program and Topics

Sessions cover clinical microbiology topics aligned with work from Centers for Disease Control and Prevention, European Centre for Disease Prevention and Control, World Health Organization, and research groups at Institut Pasteur, Rockefeller University, Scripps Research Institute, Max Planck Institute for Infection Biology, Wellcome Sanger Institute, Broad Institute, Pasteur Institute of Iran, Institute of Tropical Medicine Antwerp, National Institutes of Health, Fred Hutchinson Cancer Center, Dana-Farber Cancer Institute, and Mayo Clinic. Disciplines addressed include antimicrobial resistance studies featuring Extended-spectrum beta-lactamases research, novel diagnostics from CRISPR-based diagnostics teams, vaccine development linked to Oxford Vaccine Group, Moderna, Pfizer–BioNTech partnership, and clinical trial results coordinated with European Medicines Agency or Food and Drug Administration oversight. Topic strands include molecular epidemiology analyses employing tools from Nextstrain groups, infection prevention strategies trialed in hospitals like Charité – Universitätsmedizin Berlin and St Thomas' Hospital, antimicrobial stewardship programs pioneered by National Health Service, and One Health interfaces involving World Organisation for Animal Health collaborations.

Participation and Attendance

Typical attendance comprises thousands of delegates representing universities, hospitals, national public health institutes, industry, and NGOs, with notable participation from European Parliament health committees, representatives from Gavi, the Vaccine Alliance, Bill & Melinda Gates Foundation, regional public health agencies such as Public Health England, Santé publique France, Robert Koch Institute, and international partners including World Health Organization and Centers for Disease Control and Prevention. Delegates present poster and oral abstracts originating from laboratories at University of Oxford, University of Cambridge, Karolinska Institutet, Institut Pasteur, KU Leuven, University of Milan, University of Barcelona, Harvard Medical School, Johns Hopkins University, and Mayo Clinic.

Awards and Recognitions

The congress confers awards and honors coordinated with the European Society of Clinical Microbiology and Infectious Diseases board and academic institutions, recognizing achievements similar in prestige to prizes awarded by Wellcome Trust, Lasker Foundation, Nobel Assembly at Karolinska Institutet prize-related recognition, and discipline-specific medals endorsed by organizations such as Royal Society of Medicine and Federation of European Microbiological Societies. Categories include best poster, young investigator awards, lifetime achievement recognitions often presented to researchers affiliated with Institut Pasteur, Robert Koch Institute, University of Oxford, Harvard Medical School, and Johns Hopkins University.

Impact and Controversies

The congress has influenced guideline development at agencies such as European Centre for Disease Prevention and Control and World Health Organization through data dissemination from academic centers including Institute Pasteur, Wellcome Sanger Institute, National Institutes of Health, and Centers for Disease Control and Prevention. Controversies have occasionally arisen over industry sponsorship involving corporations like Pfizer, Gilead Sciences, Roche, and GlaxoSmithKline with debates echoed in publications from The Lancet, New England Journal of Medicine, BMJ, Nature, and Science. Other disputes involved open data and preprint policy discussions paralleling debates at Cold Spring Harbor Laboratory meetings and positions advocated by Wellcome Trust and Bill & Melinda Gates Foundation.

Category:Infectious disease conferences